Plasminogen Activator Inhibitor 1 [40208-23-7]
P4403
Estimated Purity≥95%
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NamePlasminogen Activator Inhibitor 1 [40208-23-7]
- Delivery Days Customer7
- CertificationResearch Use Only
- Estimated Purity≥95%
- Scientific DescriptionEndogenous peptide, produced by activation of PAR1; protease inhibitor.; PAI-1
- Storage Instruction-20°C
- UNSPSC12352200
References
- Gomes Giacoia E, Miyake M, Lawton A, et al. PAI-1 Leads to G1-phase Cell Cycle Progression through Cyclin D3/CDK4/6 Up-regulation. Mol Cancer Res. 2014 Jan 24. [Epub ahead of print]. PMID: 24464915. Tamura Y, Kawao N, Okada K, et al. Plasminogen activator inhibitor-1 is involved in streptozotocin-induced bone loss in female mice. Diabetes. 2013 Sep;62(9):3170-9. PMID: 23715621. Zhang YP, Wang WL, Liu J, et al. Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling. Thromb Res. 2013 Jan;131(1):64-71. PMID: 23021499. Fang H, Placencio VR, DeClerck YA. Protumorigenic activity of plasminogen activator inhibitor-1 through an antiapoptotic function. J Natl Cancer Inst. 2012 Oct 3;104(19):1470-84. PMID: 22984202. McEachron TA, Church FC, Mackman N. Regulation of thrombin-induced plasminogen activator inhibitor-1 in 4T1 murine breast cancer cells. Blood Coagul Fibrinolysis. 2011 Oct;22(7):576-82. PMID: 21799402.